News results: "OSI Pharmaceuticals" |
|
 |
|
Study: Tarceva Delays Progress Of Lung Cancer
Tarceva’s manufacturers, Genetech Inc and OSI Pharmaceuticals, said the drug proved its...
|
Lung Cancer Treatment Drug Tarceva Makes the Disease Possible To Treat
The drug Tarceva, made by OSI Pharmaceuticals has been found to cause an increase in survival rates...
|
Tarceva Slows Progress Of Lung Cancer, Study Shows
After a study disclosed that the drug Tarceva was efficient in prolonging lung cancer survival when...
|
OSI Shares Gain, Despite Preliminary Results, Tarceva Meets Its Goal
Shares of OSI Pharmaceutical rose $5.25, or 15 percent, to $40.65 at 4 p.m. New York time in Nasdaq...
|
Tarceva-Avastin Combination Doesn’t Prolong Lung Cancer Survival
According to the results of a late-stage clinical
trial into the benefits of combining Genentech’s...
|
Two-Drug Combination Isn’t Up To Snuff In Lung-Cancer Trial
Genentech Inc. and OSI Pharmaceuticals Inc., two leading biotechnology companies, announced Monday...
|
|
 |
|
| Photos Gallery |
|
|
 |
|